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The Novacor left ventricular assist system (LVAS; 
Baxter Healthcare Corporation, Novacor Division, Oak- 
land, CA) has been in clinical use since its first 
successful implantation in 1984.’ Since then, over 1,000 
patients have been implanted (personal communica- 
tion, Baxter Healthcare Corporation, Novacor Divi- 
sion, September 1999) with the Novacor device with a 
high degree of success.2 Because the device is moder- 
ately large, its implantation has always represented a 
challenge to the implanting surgeon. The original implan- 
tation of the Novacor LVAS was with the pump in the 
preperitoneal cavity, with cannulation of the left ven- 
tricular apex and the pump outflow grafts sutured to 
the supraceliac abdominal aorta.3 Subsequently, we 
developed a technique of implanting the device in the 
abdominal wall in such a way that it could connect to 
the left ventricular apex by a short cannula, with a 
much longer vascular graft to be sewn to the ascending 
aorta.4 This latter technique has been the most widely 
used for implantation of the device and has met with a 
good deal of success, although there have been some 
complications related to device implantat i~n.~ Since 
February 1998, the implantation of the Novacor LVAS 
has changed because of the introduction of a new 
cannula system. The new Vascutek cannula system 
(Sulzer Vascutek, Limited, Renfrewshire, Scotland) 
was designed to be shorter and less pliable in hopes of 
reducing the incidence of thromboembolism. However, 
this design has necessitated a change in the implantation 
technique, particularly as it affects the left hemidia- 
phragm. Although current clinical implantation of the 
Novacor LVAS still employs an externalized energy 
source and a vent for air, future derivatives of this 
device, which can be totally implanted, will almost 
certainly use the same type of abdominal wall implanta- 
tion. In this article, we will describe the current 
technique for implantation of the LVAS system using the 
Vascutek cannulae. 
The indications for LVAS support have been well 
published6 and, therefore, will not be discussed here 
except as they relate to the recipient’s size, because the 
size of the patient may have a direct relationship to the 
implantation procedure that is required. Because the 
device measures 16 X 13 X 6.5 cm, the patient 
population that can be implanted is somewhat limited 
and includes more men than women. Patients as small 
as 1 .5-m2 body surface have received the LVAS success- 
fully. However, a very tall but thin patient whose body 
surface area is greater than 1.5 m2 may be more 
technically challenging than a shorter patient with the 
same body surface area because the tall, thin patient’s 
abdominal area is simply not large enough to accommo- 
date the pump. Likewise, a poorly developed abdominal 
musculature may allow for somewhat more room for 
pump implantation but does not always provide an 
adequate covering for the pump nor are the tissues 
secure enough to close. Therefore, in assessing the 
patient’s suitability for LVAS, one must consider total 
body size measured by body surface area, body habi- 
tus, muscular development, and nutritional status and 
the ability to heal a large abdominal wound. The 
success of the Novacor LVAS implantation is well 
evidenced by the fact that 11 patients have now had the 
device in place for more than 2 years, and 2 patients 
more than 3 years (personal communication, Baxter 
Healthcare Corporation, Novacor Division, September 
1999), most of whom have had no problems with their 
implantation sites.7 
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SURGICAL TECHNIQUE 
The patient should be placed on the operating table in 
the supine position, with the appropriate monitoring 
lines to include an arterial catheter, pulmonary artery 
catheter, and generous venous access for infusion of 
blood and other fluids. After implantation of the device, 
it is frequently helpful to monitor the left atrial pres- 
sure, as well as the right atrial pressure, and the 
pulmonary artery pressure with a Swan-Ganz catheter. 
I 
1 The entire chest and abdomen should be prepared and 
draped into the sterile field in order to accommodate the large 
incision. A skin incision is made from the sternal notch to 
several centimeters below the umbilicus, taking care to encircle 
the umbilicus. 
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2 (A) The incision is carried through the subcutaneous tissue to the level of the linea alba, but the 
linea alba must be left intact. The plan is to create a pocket posterior to the rectus abdominus 
muscles but leave the posterior rectus sheaths and their attachment to the linea alba intact. 
Penetration into the abdominal cavity must be avoided in order to prevent hernia and reduce the 
risk of pocket infections. 
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2 (continued) (B) By cutting the left and right anterior rectus sheath several 
millimeters from the linea alba, it is possible to form a pocket anterior to the posterior 
rectus sheath on both sides. On the left side, the pocket should be advanced laterally past 
the linea semilunaris, below the external oblique muscles, and carried inferiorly as far as 
the iliac crest and superiorly to the left costal margin. If the patient is particularly small 
and has difficulty accommodating the pump in the abdominal pocket, a similar extension 
of the pocket can be made on the right side. It is almost always necessary to detach the 
umbilicus from its fascia1 attachment. This site needs to be securely closed with several 
sutures to prevent a hernia. The WAS pumpldrive unit (or a pump sizer) is helpful in 
determining the size and shape of the pocket in order to ensure that the pocket is of 
adequate size. It is particularly important to create the abdominal pocket before the 
administration of heparin, and we often do it before opening the sternum in order to 
reduce the incidence of bleeding. It is extremely important to prevent any bleeding 
vessels in the pocket in order to avoid the accumulation of blood in the pocket and 
subsequent infection. 
322 PENNINGTOiX AND LOHMA 
Aorta 
I 
3 Once the pocket is formed, the sternum is divided and retracted and the pericardium opened. 
At this point, the change in the technique necessitated by the introduction of the Vascutek cannula 
must be employed. The left hemidiaphragm is divided from the inferior aspect of the costal margin 
laterally to expose the left ventricular apex. The LVAS inflow cannula will cross the diaphragm 
through this defect at the level of the left ventricular apex. The LVAS outflow cannula will cross the 
diaphragm near the midline. 
The pump outflow cannula is then anastomosed to the aorta without heparinization, using a par- 
tial occlusion clamp on the ascending aorta. It is important to avoid atherosclerotic plaques in the 
aorta or old vein grafts. Sometimes it is difficult to find an area on the ascending aorta large enough 
to accommodate the moderately large outflow aortic cannula. We choose not to bevel the aortic 
cannula but sew the end of the graft directly to the side of the ascending aorta using continuous 4-0 
Prolene (Ethicon, Inc, SomerviUe, NJ). The aortic graft length must be c a r e f d y  measured at  this 
point, and therefore it is necessary to have the Vascutek cannula on the field along with the 
pumpldrive unit in order to ensure that the proper length of the aortic graft is obtained. When the 
ascending aortic graft anastomosis is accomplished, an occlusive clamp is placed on the graft, and 
the partial occlusion clamp on the aorta is removed. If there are small bleeding sites, they should be 
carefully repaired at this point before heparinization, because the large impulse of the device and 
the need for anticoagulation to institute cardiopulmonary bypass may result in bleeding at  the 
anastomotic site. We freely employ pledgeted sutures as necessary in order to ensure hemostasis. 
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4 (A) Because preparation for left ventricular cannulation requires that the heart be elevated out 
of the pericardium, it is usually necessary to initiate cardiopulmonary bypass during this part of the 
procedure. It is important that one assess the atrial septum as well as possible in order to determine 
the presence of a patent foramen ovale. This can often be done with placement of a transesophageal 
echocardiogram at the beginning of the case. If there is obviously a patent foramen ovale, the 
superior and inferior venae cavae should be encircled with canal snares in order to isolate the right 
atrium for patent foramen ovale closure. The aorta should be cannulated in the usual fashion, just 
beneath the innominate artery, and the venous cannulation should usually be bicaval in order to 
allow for a right atrial incision if needed. It is possible that a patent foramen ovale may not be 
detected until placement of the LVAS, which lowers left atrial pressure and opens the patent foramen 
ovale, creating a large right-to-left shunt that produces hypoxemia. Of course, the patient should be 
well heparinized before cannula placement in the aorta and superior and inferior venae cavae. 
The left ventricular apex is lifted out of the pericardium and elevated in order to allow the 
placement of 10 to 12 pledgeted 2-0 Ethibond (Ethicon, Inc, SomerviUe, NJ) mattress sutures 
around the apex to secure the sewing ring provided with the device to the apex of the left ventricle. 
After tying the sutures, every other suture is left uncut in order to allow for it to be placed through 
the cuff of the left ventricular cannula at the time it is introduced. (B) Cardiopulmonary bypass is 
initiated, and the patient is placed in the Trendelenburg position in order to elevate the heart and 
help prevent air embolus. With cardiopulmonary bypass well initiated and the blood cooled to 32"C, 
a stab wound is placed in the left ventricular apex. 
Folev catheter 
D 
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4 (continued) (C) We uw a cylindrical knife (cork borer) to cut a core from the left 
ventricular apex, although a scalpel may be used as well. With the cylindrical knife. we place 
a large Fole! catheter through the puncture wound in the apex and into the left ventricle. 
(D) The Foley halloon is tlisteiitlecl with saline in the left bentricular apex, and the cylindrical 
knife is used t o  core out the muscle at the left ventricular apex. The balloon forces the 
myocardial core to the outside, avoiding having it fall into the ventricle. I t  is extremely 
important not to suction deep into the left ventricle hecause of the risk of exposing the aortic 
valve and allowing air to enter the aorta, which would result in air embolus. If there is 
throinhus encountered with the incision in the left ventricular apex or with the cylindrical 
knife, we meticulously pick away the thrombus while the heart is allowed to continue to beat 
spontaneously. 
Some surgeons prefer to cross-clamp the aorta and give cardioplegia at this point8 in order 
to prevent the activity of the heart with the blood ejecting from the ventricle; however, wc do 
not heliewe that i5 nece5sary and have rarely needed to control the ventricle with 
cardioplegia ." 
4 (continued) (E) ,4s the core is removed from the left ventricular apex, the left 
ventricular cannula is introduced into the circular hole in the left ventricular apex 
and should fit securely to reduce the chance of bleeding from this site. Of course. the 
Vascutek LVGS inflow cannula has already been connected to the pump/tlrive unit 
before it is introduced into the left ventricular apex. The right hand can be used to 
grasp the left ventricular cannula and push it into the ventricle through the circular 
defect, while the left hand is used to encircle the left ventricle and push it toward the 
left ventricular cannula. In this way, a very snug fit is accomplished, with the sewing 
ring of the left ventricular apex pushed firmly against the sewing cuff on the left 
ventricular cannula. The previously placed uncut apex sutures can now be placed 
through the sewing cuff of the left ventricle and tied down in order to create a tight 
approxiination of the left ventricular apex sewing ring and the left ventricular cannula 
sewing cuff. Finally, the purse-string suture on the sewing ring, which was sutured to 
the heart, is tightened around the left ventricular cannula, tied securely, and then 
used to tie around the left ventricular cannula to prevent any motion and to further 
secure it. Other securing sutures can also be tied around the left ventricular cannula 
as needed. It is very important to have complete hemostasis aroiind the left 
ventricular cannula because it will be difficult to visualize this site once the cannula is 
connected to the LVAS and the ventricle is placed back in the pericarclium. If bleeding 
occurs from the left ventricular apex, pledgeted sutures placed in horizontal mattress 
fashion will often correct the problem. Fortunately, the pressure on the left 
ventricular apex is low if the LVAS is working well. because it decompresses the left 
ventricle. 
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5 With the inflow and outflow cannulae attached to the pumpldrive unit, which is now securely in 
the pocket, one must visualize the placement of the vented driveline. The best placement will avoid 
interference with the patient’s waist or anticipated beltline, and, if possible, the drivelines should 
exit in a downward direction. A large trocar allows it to be placed subcutaneously through the 
abdominal wall, exiting in the right mid-abdominal area. The trocar is usually placed into the 
abdominal muscle, tunneled for a distance of several centimeters in the muscle, and then passed into 
the subcutaneous tissue and finally through the exit wound in the skin. This long tract is helpful in 
preventing pump pocket infections.1° The end of the velour covering the drivelines should be just 
outside the skin exit site. The valved conduits have previously been connected to the pump housing 
and the cannula to the valved conduits so that the entire system is now intact. The mid-portion of the 
aortic cannula is elevated. We place a 20-gauge needle into the graft at that site and place a clamp on 
the aortic side of the needle. By performing repeated single-pump strokes while manipulating the 
heart, the cannula, and the pump, it is possible to remove all of the air from the pump and have it 
eject through the needle. It is also important to then clamp on the pump side of the air-venting needle 
and allow the pressure from the ascending aorta to eject through the needle in order to remove air 
from that side of the graft. The pump is then set to a slow fixed rate of 20 to 30 beats per minute. The 
patient is again placed in deep Trendelenburg position, and the vascular clamp is removed from the 
cannula. The air-venting needle is still kept at the highest position while pumping is initiated in order 
to remove any residual air. 
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Comment 
As the LVAS pumping is begun, the cardiopulmonary 
bypass circuit is gradually weaned by elevating the right 
and left atrial pressures to allow adequate preload to 
the pump and to prevent drawing air into the vascular 
system while the chest is still open. Usually, the right 
atrial pressure will exceed that of the left atrium by 10 
mm Hg, because the LVAS will markedly decompress 
the left side of the heart. The left atrial pressure catheter is 
important at this point in order to ensure that negative 
pressure is not created in the left atrium. The goal is to 
accomplish weaning from cardiopulmonary bypass and 
have the right ventricle beat sufficiently to fill the left 
pump and provide for adequate cardiac output. The 
LVAS flows in most adults will exceed 4 Wmin and the 
cardiac index is usually above 2.5 L/min/m2. Right 
atrial pressures are usually less than 20 mm Hg but may 
require infusions of isoproterenol or other inotropic 
agents, as well as vasodilating agents such as nitroglyc- 
erin, nitroprusside, or prostaglandins. In an occasional 
patient in whom right ventricular function is poor, 
inhaled nitric oxide through the endotracheal tube can 
reduce pulmonary vascular resistance and allow right 
ventricular function to improve. The chest should be 
drained with appropriate chest tubes. We place large 
Jackson-Pratt drains (Baxter Healthcare Corporation, 
Deerfield, IL) in the abdominal pocket on both sides of 
the device. These are connected to suction or bulb 
syringes and are left in place for several days until the 
drainage is less than 100 mL in 24 hours. 
The closure of the sternum and the abdominal 
incision is a critical time, particularly if there is 
borderline right ventricular function. Therefore, it is 
useful to place sternal wires and “test” by pulling the 
sternum together temporarily to assess cardiac func- 
tion. This maneuver also allows for assessment of the 
cannula position. The aortic graft may lie very close to 
the sternotomy incision and represent a risk for injury 
during reopening. If this is thought to be a problem, we 
have employed a polytetrafluoroethylene pericardial 
membrane wrap around the graft and a sheet of polytetra- 
fluoroethylene pericardial membrane immediately be- 
neath the sternum. The sternum should be closed in the 
usual fashion with stainless steel sternal wires and 
interrupted Vicryl sutures (Ethicon, Inc, Somerville, 
NJ) for the upper fascia1 portion. The abdominal 
musculature is pulled together over the device using a 
continuous monofdament running suture, and the subcu- 
taneous tissue and skin is closed in layers (Fig I). If 
there seems to be undue tension on the abdominal 
muscular closure, one can insert retention sutures as 
required, although this has rarely been needed. 
Sterile dressings are applied, and the chest tubes and 
Jackson-Pratt drains are connected to suction. It is 
extremely important that the transcutaneous cannula 
system that provides for air venting not be exposed to 
liquid. Allowing fluid to spill on the air vent site may 
impede LVAS pump function. This area must be pro- 
tected as the patient is moved off the operating room 
table into the bed. It is also helpful at the time of sternal 
and abdominal closure to remove the transesophageal 
echocardiography probe, because it often results in air 
Rectus abdominus muscle 
/I 
Exterior oblique muscle 
Interior oblique muscle 
Posterior rectus sheath ‘Transversus 
abdominus muscle 
Fig I. The abdominal closure results in complete coverage of the pump, with the anterior surface 
covered by the rectus abdominus muscle and the posterior surface covered by the posterior rectus 
sheath. 
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trapped in the stomach and unnecessary abdominal 
distension. Removal of the echocardiography probe 
and replacement with a nasogastric tube to suction out 
the stomach is often helpful in reducing the pressure as 
the abdomen is pulled together. 
It should also be noted that after the cessation of 
cardiopulmonary bypass, the heparin should be com- 
pletely reversed in the operating room without concern 
for thromboembolism. We often administer platelets, 
fresh-frozen plasma, and other agents as required to 
promote hemostasis. We have safely waited more than 
48 hours to initiate anticoagulants after the Novacor 
LVAS placement. Some investigators now advise use of a 
platelet-deaggregating drug before placement of the 
device, but that has not yet become our practice. 
This implantation technique has been used success- 
fully in a large number of patients, however, it still 
represents a challenge in small, narrow, thin patients 
with tight abdominal musculature. Occasional reopen- 
ing of the pocket is required to evacuate blood or 
hematoma, and a small incidence of pump pocket 
infections has occurred. However, in most cases, these 
infections are limited to the abdomen and have not 
involved the chest. 
The implantation technique described has been de- 
signed to provide optimal patient mobility (Fig 11). The 
implantation of the pump in the abdominal wall helps to 
stabilize the device and minimizes migration and pump 
movement. The pump becomes encased in a fibrous sac 
as healing progresses. Furthermore, there is usually 
fibrous ingrowth near the diaphragm, which effectively 
isolates the abdominal pocket. Although the technique 
is not perfect, it has proven effective. These fea- 
tures have enhanced the effectiveness of the device and 
Fig 11. The final position of the pump is shown. The primary goal of 
the implantation technique has been to provide o p t b i d  patient 
mobility and minimal pump motion. Not shown in this figure is an 
adhesive immobilization device for the driveline attached at the skin. 
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decreased the complication rate. This experience has 
provided an abundant base of knowledge, which will be 
of substantial value in developing a totally implantable 
WAS. 
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